ZA901994B - Use of human interferon-beta for stimulation of erythropoiesis - Google Patents

Use of human interferon-beta for stimulation of erythropoiesis

Info

Publication number
ZA901994B
ZA901994B ZA901994A ZA901994A ZA901994B ZA 901994 B ZA901994 B ZA 901994B ZA 901994 A ZA901994 A ZA 901994A ZA 901994 A ZA901994 A ZA 901994A ZA 901994 B ZA901994 B ZA 901994B
Authority
ZA
South Africa
Prior art keywords
beta
human interferon
erythropoiesis
stimulation
cml
Prior art date
Application number
ZA901994A
Other languages
English (en)
Inventor
Rita Michalevicz
Michalevicz Rita
Original Assignee
Interpharm Lab Ltd
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interpharm Lab Ltd, Univ Ramot filed Critical Interpharm Lab Ltd
Publication of ZA901994B publication Critical patent/ZA901994B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ZA901994A 1989-03-19 1990-03-15 Use of human interferon-beta for stimulation of erythropoiesis ZA901994B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL89662A IL89662A (en) 1989-03-19 1989-03-19 Pharmaceutical compositions comprising interferon-beta

Publications (1)

Publication Number Publication Date
ZA901994B true ZA901994B (en) 1990-12-28

Family

ID=11059803

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA901994A ZA901994B (en) 1989-03-19 1990-03-15 Use of human interferon-beta for stimulation of erythropoiesis

Country Status (12)

Country Link
US (1) US5104653A (de)
EP (2) EP0643973B1 (de)
JP (1) JP2883669B2 (de)
AT (2) ATE240116T1 (de)
AU (1) AU619960B2 (de)
CA (1) CA2011992C (de)
DE (2) DE69031355T2 (de)
DK (2) DK0388799T3 (de)
ES (2) ES2198409T3 (de)
GR (1) GR3024763T3 (de)
IL (1) IL89662A (de)
ZA (1) ZA901994B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
JP4066460B2 (ja) * 1995-07-25 2008-03-26 東レ株式会社 骨疾患治療薬
US6239109B1 (en) 1998-02-09 2001-05-29 University Of Southern California Method of promoting erythropoiesis
HU228583B1 (en) * 2000-11-07 2013-04-29 Novartis Vaccines & Diagnostic Stabilized interferon compositions
WO2002040646A1 (en) * 2000-11-14 2002-05-23 Universite Libre De Bruxelles Generation and use of dendritic cells
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US8084424B2 (en) * 2003-04-09 2011-12-27 University Of Utah Research Foundation Compositions and methods related to erythropoietin
GB2429207A (en) 2004-02-02 2007-02-21 Ambrx Inc Modified human interferon polypeptides and their uses
AU2005239995A1 (en) * 2004-03-31 2005-11-17 Nitromed, Inc. Methods for treating blood disorders with nitric oxide donor compounds
EP1984010A4 (de) * 2006-02-17 2010-09-08 Nitromed Inc Verfahren zur verwendung von hydralazinverbindungen und isosorbiddinitrat oder isosorbidmononitrat

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders

Also Published As

Publication number Publication date
CA2011992C (en) 2003-04-29
US5104653A (en) 1992-04-14
EP0643973A1 (de) 1995-03-22
IL89662A0 (en) 1989-09-28
JPH0314523A (ja) 1991-01-23
IL89662A (en) 1997-11-20
EP0388799B1 (de) 1997-09-03
DE69031355D1 (de) 1997-10-09
EP0643973B1 (de) 2003-05-14
AU619960B2 (en) 1992-02-06
GR3024763T3 (en) 1997-12-31
CA2011992A1 (en) 1990-09-19
ATE240116T1 (de) 2003-05-15
DK0643973T3 (da) 2003-09-08
DE69034076T2 (de) 2003-11-20
ES2198409T3 (es) 2004-02-01
ATE157544T1 (de) 1997-09-15
DE69031355T2 (de) 1998-01-08
DK0388799T3 (da) 1998-03-30
DE69034076D1 (de) 2003-06-18
AU5144590A (en) 1990-09-20
EP0388799A3 (de) 1991-07-31
JP2883669B2 (ja) 1999-04-19
ES2107414T3 (es) 1997-12-01
EP0388799A2 (de) 1990-09-26

Similar Documents

Publication Publication Date Title
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
IL83925A0 (en) Compositions for treatment of skin disorders
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
ZA901994B (en) Use of human interferon-beta for stimulation of erythropoiesis
IL88205A0 (en) Novel pyridine compounds and compositions for the treatment of osteoporosis
GR3035682T3 (en) Non-glycosylated fgf-4 and compositions containing the same.
EP0179808A4 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstörungen.
GB8706052D0 (en) Therapeutic compositions
ZA878812B (en) 3-(omega(3,5-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles their deoxy analogs,and therapeutic uses thereof
FR2651435B1 (de)
NZ224363A (en) Ophthalmological compositions
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
NZ222434A (en) Tissue factor protein lacking its naturally associated phospholipid
ZA884262B (en) Pharmaceutical composition for the treatment of tumors
IL90499A0 (en) Therapeutic uses of 2',5'-oligoadenylates
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
GB8808598D0 (en) Pharmaceutical compositions for treatment of prophylaxis of skin disorders
IL87475A0 (en) 4'-deshydroxyepipodophyllotoxin glucosides,their preparation and pharmaceutical compositions containing them
EP0305181A3 (en) Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin
DE3465014D1 (en) Podophyllotoxin preparations for use in the treatment of genital warts
IL79133A0 (en) Continuous release phenylethanolamine derivative compositions
ZA913644B (en) 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines and processes for their preparation
EP0491873A4 (en) Therapeutic compositions; methods for treatment of hiv infections
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
IL94402A0 (en) Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms